Amplicon details |
||
Amplicon: |
215 bp | |
1 ctcaccttgc tcctgccgag aaagtatcca tcatggctga tgcaatgcgg 51 cggctgcata cgcttgatcc ggctacctgc ccattcgacc accaagcgaa 101 acatcgcatc gagcgagcac gtactcggat ggaagccggt cttgtcgatc 151 aggatgatct ggacgaagag catcaggggc tcgcgccagc cgaactgttc 201 gccaggctca aggcg |
Record ID | Database | Record description | Record length | Taxon | Method | Amplicon size | Match details |
---|---|---|---|---|---|---|---|
NRN_DD260224 | nrnl1 | An expression vector which can cont... | 15948 bp | unidentified | QL-ELE-00-002 | 215 bp | View |
NRN_DM177632 | nrnl1 | TRANSGENIC ALOE PLANTS FOR PRODUCTl... | 4688 bp | unidentified | QL-ELE-00-002 | 215 bp | View |
NRN_DM119554 | nrnl1 | Targeting Cells With Altered miRNA ... | 5998 bp | unidentified | QL-ELE-00-002 | 215 bp | View |
NRN_DM024165 | nrnl1 | Expression of Gamma-carboxylated Po... | 7649 bp | unidentified | QL-ELE-00-002 | 215 bp | View |
NRN_DJ045711 | nrnl1 | A versatile strategy using recombin... | 9463 bp | unidentified | QL-ELE-00-002 | 215 bp | View |
NRN_DM137036 | nrnl1 | Transposition of Maize AC/DS Elemen... | 6400 bp | unidentified | QL-ELE-00-002 | 215 bp | View |
NRN_E12565 | nrnl1 | DNA which suppresses the expression... | 3603 bp | unidentified | QL-ELE-00-002 | 215 bp | View |
NRN_DM103163 | nrnl1 | HCV genome. | 8010 bp | unidentified | QL-ELE-00-002 | 215 bp | View |
NRN_DM064047 | nrnl1 | Novel method for production of prot... | 5798 bp | unidentified | QL-ELE-00-002 | 215 bp | View |
NRN_DM103162 | nrnl1 | HCV genome. | 8010 bp | unidentified | QL-ELE-00-002 | 215 bp | View |
NRN_DI079283 | nrnl1 | BIOTIN-BINDING RECEPTOR MOLECULES. | 5177 bp | unidentified | QL-ELE-00-002 | 215 bp | View |
NRN_DJ474356 | nrnl1 | DNA EXPRESSION VECTORS AND METHODS ... | 3894 bp | unidentified | QL-ELE-00-002 | 215 bp | View |
NRN_DI017686 | nrnl1 | DNA Vaccine. Antitumor Composition... | 3641 bp | unidentified | QL-ELE-00-002 | 215 bp | View |
NRN_EA261984 | nrnl1 | Sequence 33 from patent US 7235362. | 7692 bp | unidentified | QL-ELE-00-002 | 215 bp | View |
JN948506.1 | emblreltgn | Mus musculus targeted KO-first, con... | 37970 bp | Mus musculus | QL-ELE-00-002 | 215 bp | View |
NRN_EA398778 | nrnl1 | Sequence 21 from patent US 7316925. | 2725 bp | unidentified | QL-ELE-00-002 | 215 bp | View |
NRN_EA261986 | nrnl1 | Sequence 35 from patent US 7235362. | 6851 bp | unidentified | QL-ELE-00-002 | 215 bp | View |
NRN_EA398776 | nrnl1 | Sequence 19 from patent US 7316925. | 2716 bp | unidentified | QL-ELE-00-002 | 215 bp | View |
NRN_EA280819 | nrnl1 | Sequence 34 from patent US 7259015.... | 11622 bp | unidentified | QL-ELE-00-002 | 215 bp | View |
NRN_CQ821461 | nrnl1 | Sequence 17 from Patent EP1428886. | 7235 bp | unidentified | QL-ELE-00-002 | 215 bp | View |
Related publications:
Petrillo, M., et al. “JRC GMO-Amplicons: A Collection of Nucleic Acid Sequences Related to Genetically Modified Organisms.” Database (Oxford), vol. 2015 bav101, 30 Sep. 2015, doi:10.1093/database/bav101.
Angers-Loustau, A., et al. “Using the EURL GMFF Online Bioinformatics Resources: A how-to Guide for Practical JRC GMO-Matrix and JRC GMO-Amplicons Case Uses.” European Commission, Ispra, JRC101853, 2016.